These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33623416)

  • 41. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
    Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
    Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Preoperative Hypercoagulability with Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Liver Resection: A Multicenter Study.
    Zhang XP; Zhou TF; Wang ZH; Zhang F; Zhong CQ; Hu YR; Wang K; Chai ZT; Chen ZH; Wu MC; Lau WY; Cheng SQ
    Ann Surg Oncol; 2019 Nov; 26(12):4117-4125. PubMed ID: 31321582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy.
    Ahn S; Hyeon J; Park CK
    Gut Liver; 2013 Mar; 7(2):206-12. PubMed ID: 23560157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Shen A; Liu M; Zheng D; Chen Q; Wu Z
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
    Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
    Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma.
    Wang L; Jin YX; Ji YZ; Mu Y; Zhang SC; Pan SY
    World J Gastroenterol; 2020 Apr; 26(14):1647-1659. PubMed ID: 32327913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy.
    Fang T; Long G; Mi X; Su W; Mo L; Zhou L
    Front Oncol; 2022; 12():876668. PubMed ID: 35686100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
    Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
    Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion.
    Zhao H; Hua Y; Lu Z; Gu S; Zhu L; Ji Y; Qiu Y; Dai T; Jin H
    Oncotarget; 2017 Sep; 8(37):61203-61214. PubMed ID: 28977857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
    Ma WJ; Wang HY; Teng LS
    World J Surg Oncol; 2013 Aug; 11():212. PubMed ID: 23981851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy.
    Yang S; Yan HL; Tao QF; Yuan SX; Tang GN; Yang Y; Wang LL; Zhang YL; Sun SH; Zhou WP
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):109-16. PubMed ID: 24240726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
    Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
    Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
    Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
    Yamashita YI; Hayashi H; Imai K; Okabe H; Nakagawa S; Kitamura F; Uemura N; Nakao Y; Yusa T; Itoyama R; Yamao T; Umesaki N; Miyata T; Chikamoto A; Shimokawa M; Baba H
    World J Surg; 2019 Nov; 43(11):2894-2901. PubMed ID: 31312946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modified Child-Pugh grade
    Huang F; Gao J
    World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma.
    Wang J; Huang A; Wang YP; Yin Y; Fu PY; Zhang X; Zhou J
    Ann Transl Med; 2020 Mar; 8(5):237. PubMed ID: 32309384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.